Who Owns Genmab A/S
Every manager with more than $100m in listed equities files a 13F each quarter naming what they hold. These are the ones reporting a position in Genmab A/S.
Who crossed 5% of GMAB →Positions as of 2026-09-30
Largest first. The move is against the previous quarter that manager filed, not the previous calendar quarter.
| Manager | Value |
|---|---|
| Legacy Wealth Asset Management, LLCSPONSORED ADS99.9K shtrimmed | $3.6M |
| JUNCTURE WEALTH STRATEGIES, LLCSPONSORED ADS10.4K shadded | $371.9K |
| GAMMA Investing LLCADR4.8K shadded | $171K |
| Farther Finance Advisors, LLCADR2.5K shadded | $89.1K |
| ELEVATION WEALTH PARTNERS, LLCSPONSORED ADS223 shheld | $8K |
| GILPIN WEALTH MANAGEMENT, LLCSPONSORED ADS110 sh— | $3.9K |
| TOTH FINANCIAL ADVISORY CORPSPONSORED ADS60 shheld | $2.1K |
| Retirement Wealth Solutions LLCSPONSORED ADS49 shadded | $1.7K |
| CoreCap Advisors, LLCADR4 shheld | $143 |
Source: quarterly 13F filings, via EDGAR. A 13F reports positions by CUSIP alone; each CUSIP here has been confirmed against OpenFIGI rather than matched by name, because a name match would attribute one company's shareholders to another. Positions are as of quarter end and can be months old by the time they are filed, and 13F covers long equity positions only — not shorts, and not most debt. The summed value is what these filers reported, not the company's institutional ownership.
More on GMAB
Follow Genmab A/S (GMAB) by email
New trades in Genmab A/S (GMAB) by members of Congress, insiders and funds, with the rest of the week's filings. One email a week, free.
Unsubscribe with one click from any email.